ARCHIVES

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Support Contract Recompetition

July 6, 1990

Taking Tykerb With Food Increased Drug Concentration; Paper Urges More Research

July 27, 2007

IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel

November 26, 1999

Obey Strikes Again, Earmarks NCI Positions

July 2, 1976

Adjuvant Chemo Improves Survival In Early Lung Cancer

July 30, 2004

Shuttle Vector Technology Concept Approved

February 28, 1986